310 related articles for article (PubMed ID: 16187198)
1. Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.
Oda K; Iwakiri R; Hara M; Watanabe K; Danjo A; Shimoda R; Kikkawa A; Ootani A; Sakata H; Tsunada S; Fujimoto K
Dig Dis Sci; 2005 Oct; 50(10):1921-6. PubMed ID: 16187198
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of rabeprazole in gastroesophageal reflux disease: report of a multicenter study.
Kar P; Chandrashekar N; Devi S; Bhatia SJ; Alvares JF; Taneja A; Towar A
Indian J Gastroenterol; 2003; 22(4):153. PubMed ID: 12962446
[No Abstract] [Full Text] [Related]
3. Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole.
Adachi K; Hashimoto T; Hamamoto N; Hirakawa K; Niigaki M; Miyake T; Taniura H; Ono M; Kaji T; Suetsugu H; Yagi J; Komazawa Y; Mihara T; Katsube T; Fujishiro H; Shizuku T; Hattori S; Yamamoto S; Kinoshita Y
J Gastroenterol Hepatol; 2003 Dec; 18(12):1392-8. PubMed ID: 14675268
[TBL] [Abstract][Full Text] [Related]
4. The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture.
Wetscher GJ; Glaser K; Gadenstaetter M; Profanter C; Hinder RA
Am J Surg; 1999 Mar; 177(3):189-92. PubMed ID: 10219852
[TBL] [Abstract][Full Text] [Related]
5. [A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].
Jeong HY; Lee BS; Sung JK; Lee TY; Yoon SJ; Kim SJ; Chung IK; Lee SH; Shin JE; Lee DS; Baek JT; Nam SW; Yoon SJ; Kim SH; Lee GS; Lee JM; Kim AN; Oh JI
Korean J Gastroenterol; 2006 Jan; 47(1):15-21. PubMed ID: 16434864
[TBL] [Abstract][Full Text] [Related]
6. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
[TBL] [Abstract][Full Text] [Related]
7. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
Horn J
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
[TBL] [Abstract][Full Text] [Related]
8. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis.
Robinson M; Fitzgerald S; Hegedus R; Murthy A; Jokubaitis L;
Aliment Pharmacol Ther; 2002 Mar; 16(3):445-54. PubMed ID: 11876697
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group.
Dekkers CP; Beker JA; Thjodleifsson B; Gabryelewicz A; Bell NE; Humphries TJ
Aliment Pharmacol Ther; 1999 Jan; 13(1):49-57. PubMed ID: 9892879
[TBL] [Abstract][Full Text] [Related]
10. Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder.
Hong SP; Park PW; Hwang SG; Ko KH; Kwak SY; Kim SH; Kwon KS; Shin YW; Ryu JK; Ryu KH; Park SJ; Won WH; Yoo HM; Bae HM; Park MJ; Woo YK; Kim KC; Kim KH; Na SH; Kim JW
Korean J Intern Med; 2004 Jun; 19(2):93-8. PubMed ID: 15366639
[TBL] [Abstract][Full Text] [Related]
11. Rabeprazole is latest entrant in proton-pump-inhibitor class.
Miller JL
Am J Health Syst Pharm; 1999 Oct; 56(19):1910. PubMed ID: 10554904
[No Abstract] [Full Text] [Related]
12. Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.
Archimandritis AJ; Nikolopoulou V; Kouklakis G; Paraskevas E; Avgerinos A; Tsianos E; Triantafillidis JK;
Curr Med Res Opin; 2005 Apr; 21(4):603-10. PubMed ID: 15899110
[TBL] [Abstract][Full Text] [Related]
13. Heartburn severity can predict pathologic oesophageal reflux in gastro-oesophageal reflux disease patients treated with a proton-pump inhibitor.
Gardner JD; Sloan S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2003 Jul; 18(1):133-40. PubMed ID: 12848635
[TBL] [Abstract][Full Text] [Related]
14. Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group.
Caos A; Moskovitz M; Dayal Y; Perdomo C; Niecestro R; Barth J
Am J Gastroenterol; 2000 Nov; 95(11):3081-8. PubMed ID: 11095321
[TBL] [Abstract][Full Text] [Related]
15. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
Hall J; Dodd S; Durkin M; Sloan S
Manag Care; 2002 Jul; 11(7 Suppl):14-8. PubMed ID: 12181872
[TBL] [Abstract][Full Text] [Related]
16. [The impact of rabeprazole treatment on the quality of life in patients with reflux esophagitis and non-erosive reflux disease].
Liu XH; Ke MY; Song ZQ; Luo JY; Yuan YZ; Hou XH; Zhu YL; Sun J; Zha H
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):818-21. PubMed ID: 16316559
[TBL] [Abstract][Full Text] [Related]
17. Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.
Miner P
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():20-9. PubMed ID: 15496215
[TBL] [Abstract][Full Text] [Related]
18. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
19. [A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study].
Jee SR; Seol SY; Kim DH; Park SJ; Han SY; Urm SH; Lee JT
Korean J Gastroenterol; 2005 May; 45(5):321-7. PubMed ID: 15908764
[TBL] [Abstract][Full Text] [Related]
20. Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.
Lim PW; Goh KL
J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S61-8. PubMed ID: 15324384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
